RIGEL PHARMACEUTIC earnings per share and revenue

RIGL earnings per share for the last quarter are 0.56 CHF whereas the estimation was 0.08 CHF which accounts for 605.80% surprise. Company revenue for the same period amounts to 47.21 M CHF despite the estimated figure of 38.84 M CHF. Estimated earnings per share for the next quarter are 1.16 CHF, and revenue is expected to reach 56.62 M CHF. Also watch annual changes over time to get a bigger picture of RIGL earnings per share and revenue dynamics.